Pharmdeko (PHARMDE)

Currency in NGN
1.830
0.000(0.00%)
Closed·

PHARMDE Income Statement

Period Ending:
2013
31/12
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-10.12%-17.87%-28.3%-46.89%+89.51%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa657.34530.8381.94217.56411.04
aa.aaaa.aaaa.aaaa.aaaa.aa-11.12-0.07-1.39-15.46-28.04
* In Millions of NGN (except for per share items)

FAQ

What was Pharmdeko’s revenue at year end?

At the end of the last reported fiscal year, Pharmdeko (PHARMDE) recorded total revenue of 469.584 million NGN.

How much revenue did Pharmdeko report in the most recent quarter?

In its most recent quarterly earnings report, Pharmdeko posted revenue of 120.516 million NGN.

What was Pharmdeko’s net income for the year?

For the full year, Pharmdeko reported net income of -296.186 million NGN.

How much net income did Pharmdeko post in the last quarter?

In the most recent quarter, Pharmdeko (PHARMDE) posted net income of -32.375 million NGN.

What was Pharmdeko’s gross profit for the year?

Gross profit for the year was reported at 97.619 million NGN.

How much gross profit did Pharmdeko generate last quarter?

Pharmdeko recorded gross profit of 7.293 million NGN in its latest quarterly report.

What was Pharmdeko’s annual operating income?

For the full year, Pharmdeko (PHARMDE) reported operating income of -285.382 million NGN.

What was Pharmdeko’s operating income last quarter?

Quarterly operating income was -30.902 million NGN.

What was Pharmdeko’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -13.616 million NGN.

What was the quarter-over-quarter change in EBITDA for Pharmdeko?

EBITDA changed by 49.258% million NGN compared to the last quarter.

What is Pharmdeko’s most recent gross profit margin?

The latest reported gross profit margin for Pharmdeko (PHARMDE) is 6.051% million NGN.

What is Pharmdeko’s most recent net income margin?

Net income margin based on recent financials is -26.864% million NGN.

What is Pharmdeko’s most recent EBIT margin?

Pharmdeko reported an EBIT margin of -25.641% million NGN based on current figures.

How did Pharmdeko’s revenue change compared to the previous quarter?

Revenue changed by 11.191% million NGN compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Pharmdeko?

In the latest quarter, gross profit changed by 229.527% million NGN from the previous quarter.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.